Research & Partnership Highlights
(FY21–Present)
Research Pipeline
25 active research projects
3 compounds currently in Phase I clinical trials
Intellectual Property
Over 100 U.S. issued patents
More than 500 published patent applications
Collaborations
36 active partnerships with bhd aniotec pharmaceutical companies
* Types include partnered research, co-funded projects, and shared target discovery
Funded Research Projects
35 research initiatives funded since FY21
* Total projected funding exceeds $52 million
Estimated Partnership Costs
Average cost per partnership ranges from $325K to $350K (excluding indirect costs)
View our Collaborations




































